| Study to Investigate the Efficacy and the Safety of M518101 in Plaque Psoriasis Patients (NCT01301157) | Maruho Co., Ltd. | 2011-02-01 |
| Divided Dose of TRAVATAN® (NCT01298687) | Alcon Research | 2011-02-01 |
| Clinical Investigation of the MiStent Drug Eluting Stent (DES) in Coronary Artery Disease (NCT01294748) | Micell Technologies | 2011-02-01 |
| Platelet Rich Plasma Injection for Knee Pain (NCT01747018) | The Catholic University of Korea | 2011-02-01 |
| Neoadjuvant Axitinib in Locally Advanced Renal Cell Carcinoma (RCC) (NCT01263769) | M.D. Anderson Cancer Center | 2011-02-01 |
| Autologous Bone Marrow Cell Transplantation in Persons With Acute Spinal Cord Injury- An Indian Pilot Study. (NCT02260713) | Indian Spinal Injuries Centre | 2011-02-01 |
| Coenzyme Q10 in Post-Cardiac Arrest Cerebral Resuscitation (NCT01319110) | Beth Israel Deaconess Medical Center | 2011-02-01 |
| The Role of Traditional Chinese Medicine in the Treatment of Chronic Childhood Immune Thrombocytopenia (ITP) (NCT01226524) | Hadassah Medical Organization | 2011-02-01 |
| TC-6987 for the Treatment of Mild to Moderate Asthma (NCT01296087) | Targacept Inc. | 2011-02-01 |
| AR-12286 in Combination With Latanoprost (NCT01302249) | Aerie Pharmaceuticals | 2011-02-01 |
| A Study of Safety, Tolerability, and Evidence of Activity of FCFD4514S Administered Monthly or Every Other Month to Patients With Geographic Atrophy (NCT01229215) | Genentech, Inc. | 2011-02-01 |
| Addition of Ipilimumab (MDX-010) To Isolated Limb Infusion (ILI) With Standard Melphalan and Dactinomycin In The Treatment of Advanced Unresectable Melanoma of The Extremity (NCT01323517) | Memorial Sloan Kettering Cancer Center | 2011-02-01 |
| Exploratory Study of Farletuzumab to Treat Resectable, Non-functioning Pituitary Adenomas (NCT01203618) | Morphotek | 2011-02-01 |
| Evaluation of the Genu Neurexa Orthosis in Post Stroke Patients (NCT01395576) | Hadassah Medical Organization | 2011-02-01 |
| A Trial of TBL12 Sea Cucumber Extract in Patients With Untreated Asymptomatic Myeloma (NCT01302366) | NYU Langone Health | 2011-02-01 |
| Trial of Combination Antifungal Therapy (Vori+Mica vs. Vori+Placebo) in Invasive Aspergillosis (NCT01207128) | University of Arkansas | 2011-02-01 |
| Randomized Study to Evaluate the Effect of an Investigational Product on Weight Loss and Body Composition (NCT01272739) | Avera McKennan Hospital & University Health Center | 2011-02-01 |
| Testing Delivery Channels of Brief Motivational Alcohol Intervention (NCT01291693) | University Medicine Greifswald | 2011-02-01 |
| Topical ASC-J9 Cream for Acne (NCT01289574) | AndroScience Corp | 2011-02-01 |
| Dietary Antioxidants, Redox Tone and Health Promotion: an Orthomolecular Study of Interactions (NCT01315977) | The Hong Kong Polytechnic University | 2011-02-01 |
| Safety Study of Combined Systemic and Intraperitoneal Chemotherapy to Treat Stomach Cancer (NCT01525771) | Asan Medical Center | 2011-02-01 |
| Evaluation of Anti-Inflammatory Treatment in Dry Eye Patients (NCT01276223) | Alcon Research | 2011-02-01 |
| Treadmill, Stretching and Proprioceptive Exercise (TreSPE) Rehabilitation Program for Charcot-Marie-Tooth Neuropathy Type 1A (CMT1A) (NCT01289704) | University of Genova | 2011-02-01 |
| Effect of Intrathecal Clonidine in Hypertensive Subjects With Poorly Controlled Blood Pressure (NCT01297335) | The Center for Clinical Research, Winston-Salem, NC | 2011-02-01 |
| Pharmacodynamics, Pharmacokinetics, Safety and Tolerability of PTH Analog Tablets in Postmenopausal Women (NCT01321723) | Unigene Laboratories Inc. | 2011-02-01 |
| Efficacy and Safety Clinical Trial of the Combination of Acetylsalicylic Acid, Sodium Bicarbonate and Citric Acid, Produced by Geolab Pharmaceutical Industries Ltd., Compared to Acetylsalicylic Acid (Aspirin ® - Bayer) in Patients With Episodic Tension-type Headache. (NCT01012349) | Azidus Brasil | 2011-02-01 |
| Zambia Chlorhexidine Application Trial (NCT01241318) | Boston University | 2011-02-01 |
| Efficacy of NNC109-0012 in Subjects With Active Rheumatoid Arthritis (NCT01282255) | Novo Nordisk A/S | 2011-02-01 |
| Determination of the Optimum Delivery Route for Botulinum Toxin A in Patients With Epiphora (NCT01282541) | Merbs, Shannath, M.D., Ph.D. | 2011-02-01 |
| Continuing vs Intermittent Trabectedin in Patients With Advanced Soft Tissue Sarcoma (NCT01303094) | Centre Oscar Lambret | 2011-02-01 |
| Accelerated Fractionation Radiotherapy (AFRT) Versus Concurrent Chemoradiotherapy (Crt) In Locally Advanced Head And Neck Squamous Cell Carcinoma (NCT01291095) | All India Institute of Medical Sciences | 2011-02-01 |
| Safety and Efficacy Study of Autologous Bone Marrow Derived Stem Cell Treatment in Amyotrophic Lateral Sclerosis (NCT01363401) | Corestemchemon, Inc. | 2011-02-01 |
| A Phase I Dose Finding and Safety Study of Oral LDE225 in Children and a Phase II Portion to Assess Preliminary Efficacy in Recurrent or Refractory MB (NCT01125800) | Novartis Pharmaceuticals | 2011-02-01 |
| Vitamin D Supplementation and Male Infertility: The CBG-study a Randomized Clinical Trial (NCT01304927) | Rigshospitalet, Denmark | 2011-02-01 |
| Influence of Thoracolumbar Proprioceptive Support in the Segmental Stabilization Training (NCT01481857) | Universidade Federal do Piauí | 2011-02-01 |
| Combined STN/SNr-DBS for the Treatment of Refractory Gait Disorders in Parkinson's Disease (NCT01355835) | University Hospital Tuebingen | 2011-02-01 |
| Study of Velcade and Temsirolimus for Relapsed or Refractory Non-Hodgkin Lymphoma (NCT01281917) | University of Wisconsin, Madison | 2011-02-01 |
| Ulinastatin in Inhalation Lung Injury (NCT01287806) | Chinese PLA General Hospital | 2011-02-01 |
| Growth Hormone (GH) in in Vitro Fertilization (IVF) Poor-responder Patients (NCT01298960) | Fundacion Dexeus | 2011-02-01 |
| Mesenchymal Stem Cells in the Treatment of Relapsed/Refractory Severe Acquired Aplastic Anemia (NCT01297972) | University of Sao Paulo | 2011-02-01 |
| Bevacizumab as Adjunctive Treatment to Laser Panretinal Photocoagulation for Proliferative Diabetic Retinopathy (NCT01389505) | Instituto do Coracao | 2011-02-01 |
| Trabectedin in Treating Patients With Metastatic Pancreatic Cancer After First-Line Chemotherapy (NCT01339754) | IRCCS San Raffaele | 2011-02-01 |
| Treatment of Non-infectious Intermediate and Posterior Uveitis Associated Macular Edema With Intravitreal Methotrexate (NCT01314417) | National Eye Institute (NEI) | 2011-02-01 |
| The Effect of Vorinostat on HIV RNA Expression in the Resting CD4+ T Cells of HIV+ Pts on Stable ART (NCT01319383) | University of North Carolina, Chapel Hill | 2011-02-01 |
| Efficacy of System Constellations in a General Population (NCT01352325) | Heidelberg University | 2011-02-01 |
| Evaluation of the Effect of AZD5069 in Patients With Bronchiectasis (NCT01255592) | AstraZeneca | 2011-02-01 |
| Safety and Efficacy Study of Idelalisib (GS-1101, CAL-101) in Patients With Previously Treated Low-grade Lymphoma (NCT01306643) | Gilead Sciences | 2011-02-01 |
| A Study To Investigate The Safety And Possible Clinical Benefit Of Multistem(r) In Patients With Moderate To Severe Ulcerative Colitis (NCT01240915) | Pfizer | 2011-02-01 |
| Effect of Different Doses of SAR110894 on Cognition in Patients With Mild to Moderate Alzheimer's Disease on Donepezil (NCT01266525) | Sanofi | 2011-02-01 |
| Panobinostat Plus Ifosfamide, Carboplatin, and Etoposide (ICE) Compared With ICE For Relapsed Hodgkin Lymphoma (NCT01169636) | M.D. Anderson Cancer Center | 2011-01-31 |
| Cyclosporine Inhalation Solution (CIS) in Lung Transplant and Hematopoietic Stem Cell Transplant Recipients for the Treatment of Bronchiolitis Obliterans Syndrome (NCT01287078) | National Heart, Lung, and Blood Institute (NHLBI) | 2011-01-29 |
| Akt Inhibitor MK2206 or Everolimus in Treating Patients With Refractory Kidney Cancer (NCT01239342) | National Cancer Institute (NCI) | 2011-01-27 |
| A Phase I/II Trial of Crolibulin (EPC2407) Plus Cisplatin in Adults With Solid Tumors With a Focus on Anaplastic Thyroid Cancer (ATC) (NCT01240590) | National Cancer Institute (NCI) | 2011-01-26 |
| AN2728 Topical Ointment to Treat Mild-to-Moderate Plaque-Type Psoriasis (NCT01300052) | Pfizer | 2011-01-26 |
| Pazopanib as Single Agent in Advanced NETs (NCT01280201) | Grupo Espanol de Tumores Neuroendocrinos | 2011-01-26 |
| Vorinostat, Temozolomide, or Bevacizumab in Combination With Radiation Therapy Followed by Bevacizumab and Temozolomide in Young Patients With Newly Diagnosed High-Grade Glioma (NCT01236560) | National Cancer Institute (NCI) | 2011-01-26 |
| Prevention of Treatment Induced Neuropathy in Multiple Myeloma (NCT01283997) | M.D. Anderson Cancer Center | 2011-01-25 |
| Efficacy, Safety and Tolerability of Cadazolid in Subjects With Clostridium Difficile Associated Diarrhea (CDAD) (NCT01222702) | Actelion | 2011-01-25 |
| Clofarabine and Low-Dose Total-Body Irradiation in Treating Patients With Acute Myeloid Leukemia Undergoing Donor Peripheral Blood Stem Cell Transplant (NCT01252667) | Fred Hutchinson Cancer Center | 2011-01-25 |
| Study of Nilotinib as First Line Treatment in Philadelphia Chromosome Positive(Ph+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP) (NCT01274351) | Novartis Pharmaceuticals | 2011-01-25 |
| Evaluation of Cortisol Resistance in Young Sedentary and Endurance-Trained Men (NCT01294319) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2011-01-24 |
| Sequential Two-agent Assessment in Renal Cell Carcinoma Therapy: The START Trial (NCT01217931) | M.D. Anderson Cancer Center | 2011-01-19 |
| Evaluation of the Efficacy and Safety of ADL5945 Once Daily for the Treatment of Opioid-induced Constipation in Adults Taking Opioid Therapy for Chronic Noncancer Pain (NCT01275755) | Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2011-01-19 |
| Aldesleukin With or Without Ziv-Aflibercept in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery (NCT01258855) | National Cancer Institute (NCI) | 2011-01-18 |
| Irinotecan Hydrochloride and Cetuximab With or Without Ramucirumab in Treating Patients With Advanced Colorectal Cancer With Progressive Disease After Treatment With Bevacizumab-Containing Chemotherapy (NCT01079780) | Eastern Cooperative Oncology Group | 2011-01-18 |
| BLP25 Liposome Vaccine and Bevacizumab After Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Stage IIIA or Stage IIIB Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery (NCT00828009) | ECOG-ACRIN Cancer Research Group | 2011-01-17 |
| Safety And Efficacy Of Oral PF-4136309 In Patients With Chronic Hepatitis C Infection And Abnormal Liver Enzymes (NCT01226797) | Pfizer | 2011-01-17 |
| Safety and Immunogenicity Study of a Candidate Tuberculosis Vaccine in Human Immunodeficiency Virus (HIV)-Positive Adults (NCT01262976) | GlaxoSmithKline | 2011-01-17 |
| Panobinostat in Treating Patients With Relapsed or Refractory Non-Hodgkin Lymphoma (NCT01261247) | Mayo Clinic | 2011-01-17 |
| Safety/Tolerability/Pharmacokinetic (PK)/Pharmacodynamics (PD) Study of BMN701 in Patients With Late-Onset Pompe Disease (NCT01230801) | BioMarin Pharmaceutical | 2011-01-17 |
| WT1 Vaccine Treatment of Patients in Remission From Acute Myeloid Leukemia (AML) or Acute Lymphoblastic Leukemia (ALL) (NCT01266083) | Sellas Life Sciences Group | 2011-01-14 |
| Dasatinib and Gemcitabine Hydrochloride or Gemcitabine Hydrochloride Alone in Treating Patients With Pancreatic Cancer Previously Treated With Surgery (NCT01234935) | Translational Oncology Research International | 2011-01-13 |
| Safety and Immunogenicity of GSK Biologicals' Malaria Vaccine 257049 When Administered on 7 Schedules to African Infants (NCT01231503) | GlaxoSmithKline | 2011-01-13 |
| Phase II ABT-888 With Cyclophosphamide (NCT01306032) | National Cancer Institute (NCI) | 2011-01-12 |
| A Clinical Trial Using Metronomic Oral Low-dose Cyclophosphamide Alternating With Low-dose Oral Methotrexate With Continuous Celecoxib and Weekly Vinblastine in Children and Adolescents With Relapsed or Progressing soliD Tumours. (NCT01285817) | Assistance Publique Hopitaux De Marseille | 2011-01-12 |
| Capecitabine Versus Bolus 5-Fu Associated to Radiotherapy as Neoadjuvant Treatment for Rectal Cancer. (NCT03428529) | Instituto Nacional de Cancer, Brazil | 2011-01-12 |
| Azacitidine in Treating Patients With Previously Treated Advanced Non-Small Cell Lung Cancer (NCT01281124) | National Cancer Institute (NCI) | 2011-01-12 |
| Effect of Donepezil on Smoking (NCT01250977) | Abramson Cancer Center at Penn Medicine | 2011-01-11 |
| Everolimus and Lenalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin or Hodgkin Lymphoma (NCT01075321) | Mayo Clinic | 2011-01-10 |
| A Randomized, Placebo-controlled, Double-blind Phase 2 Study With OSI-906 in Patients With Advanced HCC (NCT01101906) | Astellas Pharma Inc | 2011-01-10 |
| Reduced-Intensity Busulfan and Fludarabine With or Without Antithymocyte Globulin Followed by Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease (NCT00448201) | UNC Lineberger Comprehensive Cancer Center | 2011-01-07 |
| PRX-00023 Therapy in Localization-Related Epilepsy (NCT01281956) | National Institute of Neurological Disorders and Stroke (NINDS) | 2011-01-07 |
| Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer (NCT01124695) | ECOG-ACRIN Cancer Research Group | 2011-01-07 |
| Paclitaxel, Trastuzumab, and Pertuzumab in the Treatment of Metastatic HER2-Positive Breast Cancer (NCT01276041) | Memorial Sloan Kettering Cancer Center | 2011-01-05 |
| YF476 and Type I Gastric Carcinoids (NCT01339169) | Trio Medicines Ltd. | 2011-01-04 |
| SGI-110 in Participants With Myelodysplastic Syndromes (MDS) or Acute Myelogenous Leukemia (AML) (NCT01261312) | Astex Pharmaceuticals, Inc. | 2011-01-04 |
| Efficacy and Safety of Ambrisentan in Children 8-18yrs (NCT01332331) | GlaxoSmithKline | 2011-01-04 |
| ABT-888 With Modified FOLFOX6 in Patients With Metastatic Pancreatic Cancer (NCT01489865) | Georgetown University | 2011-01-03 |
| Probiotic Intervention With Elderly Subjects (NCT01475942) | Danisco | 2011-01-01 |
| Hypofractionated Stereotactic Body Radiation Therapy (SBRT) (NCT01288534) | University of Michigan Rogel Cancer Center | 2011-01-01 |
| Study to Assess Efficacy and Safety of Anti-von Willebrand Factor (vWF) Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (aTTP) (NCT01151423) | Ablynx, a Sanofi company | 2011-01-01 |
| AMES Treatment of the Impaired Leg in Chronic Stroke Patients (NCT01378637) | AMES Technology | 2011-01-01 |
| Prevention of Micro-architectural Bone Decay in Males With Non-metastatic Prostate Cancer Receiving Androgen Deprivation Therapy (ADT) (NCT01006395) | Austin Health | 2011-01-01 |
| QuitAdvisorMD: A Point-of-care Tool for Brief Smoking Cessation Interventions (NCT01065493) | Silverchair Science & Communications, LLC | 2011-01-01 |
| ITT4 Intratesticular Hormonal Milieu in Man (ITT4) (NCT01215292) | University of Washington | 2011-01-01 |
| Neurofeedback Study ADHD (NCT01879644) | Philipps University Marburg | 2011-01-01 |
| Standard of Care (SOC) With or Without CTS-1027 in Hepatitis C (HCV) Null-Responders (NCT01273064) | Conatus Pharmaceuticals Inc. | 2011-01-01 |
| Pazopanib Hydrochloride in Treating Patients With Recurrent or Persistent Uterine Cancer (NCT01247571) | National Cancer Institute (NCI) | 2011-01-01 |
| Bone Loss and Immune Reconstitution in HIV/AIDS (BLIR-HIV) (NCT01228318) | Emory University | 2011-01-01 |
| Decidual Stromal Cells as Treatment for Acute Graft Versus Host Disease, a Phase 1-2 Study (NCT02172937) | Karolinska Institutet | 2011-01-01 |